Skip to content

A prospective randomized control study of pancreatic pseudocysts combined with pancreatic duct stent placed by endoscopy andpercutaneous external drainage

A prospective randomized control study of pancreatic pseudocysts combined with pancreatic duct stent placed by endoscopy andpercutaneous external drainage

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ICR-15007161
Enrollment
Unknown
Registered
2015-09-07
Start date
2015-10-08
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic pseudocysts

Interventions

Trial group:percutaneous catheter drainage + pancreatic stent drainage
control group:pancreatic stent drainage / gastroduodenal transmural drainage

Sponsors

Department of Hepatobiliary Surgery, Xinqiao Hospital of Third Military Medical University, Chongqing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. aged: 18-70 years old; 2. exceed 4 weeks after acute pancreatitis; 3. the definition of pseudocyst (2012 revised classification criteria Atlanta): namely enhanced CT or EUS showed homogeneous low density area around the cyst fluid accumulation was significantly enhanced, excluding non-liquid ingredients; 4. the following symptoms or complications: oppression of the stomach or duodenum cause bloating, nausea, vomiting, pain andother symptoms; oppression caused by the common bile duct stenosis or cholestasis; cyst larger than 5cm, formed more than 4 weeks of its shape andsize unchanged or larger.

Exclusion criteria

Exclusion criteria: 1. the incidence of acute pancreatitis in 4 weeks; 2. infection or bleeding; 3. cysts less than 4cm; 4. severe heart,lung, liver disease, coagulation disorders, andthere are other endoscopic contraindications; 5. pregnant or lactating women; 6. refused to sign an informed consent.

Design outcomes

Primary

MeasureTime frame
Cure rate;recurrence rate of pancreatic pseudocysts;The complication rate;hospital stays;

Secondary

MeasureTime frame
Operation rate;Mortality rate;Total hospitalization expenses;

Countries

China

Contacts

Public ContactXiaobing Huang
huang-x-b@163.com+86 13372618116

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026